High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,563,392
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-25
$126,451
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-25 | $126,451 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-18
$174,314
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-18 | $174,314 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-17
$298,081
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-17 | $298,081 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-13
$749,985
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-13 | $749,985 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-11
$214,560
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-11 | $214,560 | S | Form 4 |